News Daily News Myocardial Injury After Cardiac Surgery: Time for New hs-cTnT Thresholds? Yael L. Maxwell September 19, 2023
News Daily News High-risk Plaques in Nonculprit Lesions Tied to Worse Post-MI Outcomes Caitlin E. Cox September 18, 2023
News Daily News European Regulators Investigating CV Safety of Weight-Loss Drug Mysimba Michael O'Riordan September 15, 2023
News Daily News Evinacumab Helps Severe Hypercholesterolemia Patients Reach LDL Targets Michael O'Riordan September 14, 2023
News Daily News Pre-TAVI PCI Linked to More Late Bleeding, With Implications for Survival L.A. McKeown September 14, 2023
News Daily News Prescribing a Generic for CVD? Plan, Drug Type, and Condition Impact Availability Todd Neale September 13, 2023
News Daily News ‘Functional’ SYNTAX Score May Hone PCI, CABG Choices in Multivessel Disease Michael O'Riordan September 13, 2023
News Daily News CAC Found on Noncardiac CT Scans Linked to Prognosis Yael L. Maxwell September 12, 2023
News Daily News Nonwhite Cardiac Arrest Victims Are More Likely to Die Prehospital: Why? L.A. McKeown September 11, 2023
News Daily News Worldwide, Care for Women With Acute HF Falls Short Caitlin E. Cox September 08, 2023
News Daily News Balloon-Expandable Redo TAVI Shows Promise in Real-world Cohort Yael L. Maxwell September 06, 2023
News Conference News ESC 2023 ESC Issues New ACS Guidelines: Directions on Invasive Timing, DAPT, and More Michael O'Riordan September 06, 2023
News Conference News ESC 2023 ESC/EACTS Task Force Recommends Downgrading PCI in Left Main CAD Michael O'Riordan September 05, 2023
News Daily News Unguided De-escalation, Short DAPT the Best Strategies in ACS: Meta-analysis Yael L. Maxwell September 05, 2023
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for August 2023 Caitlin E. Cox September 04, 2023
News Daily News First Drugs Chosen for Medicare Negotiations Hit Close to Home for Cardiologists L.A. McKeown August 31, 2023
News Conference News ESC 2023 More Details on Acoramidis’ Benefit in ATTR Cardiomyopathy: ATTRibute-CM Michael O'Riordan August 31, 2023